Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New partner and name change for German law firm

This article was originally published in Clinica

Executive Summary

German law firm Lützeler Klümper Wachenhausen Rechtsanwälte has a new partner and a new name. Heike Wachenhausen, who joined the firm recently, previously worked with Claudia Lützeler and Mathias Klümper in the industry group Healthcare, Life Sciences and Chemicals at Clifford Chance. The latter two set up their own firm in 2007. Dr Wachenhausen is also a former head of legal regulatory and development at Novartis Pharma AG in Basel, Switzerland. Lützeler Klümper Wachenhausen Rechtsanwälte, which was originally called Lützeler und Partner Rechtsanwälte, specialises in pharmaceutical, medical products and biotechnology law.

You may also be interested in...



Decision Time For MSD/AZ, Lilly, Kite EU Fast-Track Hopes

Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.

EMA Prepares Approval Verdict On Beovu, Idhifa, Recarbrio

Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.

Orchard’s Gene Therapy Under Fast-Track Review At EMA

A handful of new products are under review at the European Medicines Agency. Orchard Therapeutics' gene therapy application will be fast-tracked; Roche's filing for its new flu treatment will not.

Topics

UsernamePublicRestriction

Register

MT097865

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel